Cargando…

Comparison of Lipoprotein-Associated Phospholipase A2 and High Sensitive C-Reactive Protein as Determinants of Metabolic Syndrome in Subjects without Coronary Heart Disease: In Search of the Best Predictor

High sensitivity C-reactive protein (hsCRP) is a marker of metabolic syndrome (MS) and cardiovascular (CV) disease. Lipoprotein-associated phospholipase A2 (Lp-PLA2) also predicts CV disease. There are no reports comparing these markers as predictors of MS. Methods. Cross-sectional study comparing L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Acevedo, Mónica, Varleta, Paola, Kramer, Verónica, Valentino, Giovanna, Quiroga, Teresa, Prieto, Carolina, Parada, Jacqueline, Adasme, Marcela, Briones, Luisa, Navarrete, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452297/ https://www.ncbi.nlm.nih.gov/pubmed/26089902 http://dx.doi.org/10.1155/2015/934681

Ejemplares similares

Impaired Fasting Glucose in Nondiabetic Range: Is It a Marker of Cardiovascular Risk Factor Clustering?
por: Valentino, Giovanna, et al.
Publicado: (2015)

Does Good Aerobic Capacity Attenuate the Effects of Aging on Cardiovascular Risk Factors? Results from a Cross-Sectional Study in a Latino Population
por: Valentino, Giovanna, et al.
Publicado: (2017)

Cardiorespiratory fitness improves prediction of mortality of standard cardiovascular risk scores in a Latino population
por: Acevedo, Mónica, et al.
Publicado: (2020)

Mobile-phone text messaging to promote ideal cardiovascular health in women
por: Acevedo, Monica, et al.
Publicado: (2023)

Low Cardiovascular Disease Awareness in Chilean Women: Insights from the ESCI Project
por: Varleta, Paola, et al.
Publicado: (2020)

Prevalence and determinants of ideal cardiovascular health in a latin women cohort: a cross-sectional study
por: Acevedo, Mónica, et al.
Publicado: (2021)

High-sensitivity C-reactive protein, lipoprotein-related phospholipase A(2), and acute ischemic stroke
por: Kara, Hasan, et al.
Publicado: (2014)

Lipoprotein‐associated phospholipase A2: The story continues
por: Huang, Fubao, et al.
Publicado: (2019)

Lipoprotein-Associated Phospholipase A(2) Mass Level Is Increased in Elderly Subjects with Type 2 Diabetes Mellitus
por: Fortunato, J., et al.
Publicado: (2014)

Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
por: Passaro, Angelina, et al.
Publicado: (2018)

Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease
por: Doody, Rachelle S., et al.
Publicado: (2015)

Racial variation in lipoprotein-associated phospholipase A(2 )in older adults
por: Lee, Keane K, et al.
Publicado: (2011)

Secreted phospholipase A(2), lipoprotein hydrolysis, and atherosclerosis: integration with lipidomics
por: Yamamoto, Kei, et al.
Publicado: (2011)

Elevated Lipoprotein-Associated Phospholipase A2 Is Associated With Intracranial Atherosclerosis
por: Wang, Yuan, et al.
Publicado: (2022)

Lipoprotein-Associated Phospholipase A(2), Vascular Inflammation and Cardiovascular Risk Prediction
por: Sudhir, Krishnankutty
Publicado: (2006)

Is lipoprotein-associated phospholipase A(2) correlated with cardiovascular risk in European women?
por: Hirschler, V.
Publicado: (2013)

Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories
por: Dhamoon, Mandip S., et al.
Publicado: (2019)

The correlation between lipoprotein associated phospholipase A(2) and central overweight status
por: Chen, Yi-Hsuan, et al.
Publicado: (2021)

Lipoprotein-associated phospholipase A(2): A paradigm for allosteric regulation by membranes
por: Mouchlis, Varnavas D., et al.
Publicado: (2022)

Lipoprotein-Associated Phospholipase A2 Activity as Potential Biomarker of Vascular Dementia
por: Zuliani, Giovanni, et al.
Publicado: (2023)

The diagnostic value of lipoprotein-associated phospholipase A2 in early diabetic nephropathy
por: Zhai, Yan, et al.
Publicado: (2023)

Lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in young patients with acute coronary syndrome in China
por: Huang, Yuli, et al.
Publicado: (2017)

Elevated lipoprotein(a) and lipoprotein-associated phospholipase A(2) are associated with unfavorable functional outcomes in patients with ischemic stroke
por: Jiang, Xue, et al.
Publicado: (2021)

Association between high‐sensitivity C‐reactive protein, lipoprotein‐associated phospholipase A2 and carotid atherosclerosis: A cross‐sectional study
por: Liu, Huamin, et al.
Publicado: (2018)

Active site competition is the mechanism for the inhibition of lipoprotein-associated phospholipase A(2) by detergent micelles or lipoproteins and for the efficacy reduction of darapladib
por: Zhuo, Shaoqiu, et al.
Publicado: (2020)

Effects of dl‐3‐n‐butylphthalide on serum lipoprotein‐associated phospholipase A2 and hypersensitive C‐reactive protein levels in acute cerebral infarction
por: Zhang, Xiao‐Lei, et al.
Publicado: (2019)

Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis
por: Gong, Hui-ping, et al.
Publicado: (2011)

Association of Lipoprotein-Associated Phospholipase A(2) with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
por: Liu, Yu-Sheng, et al.
Publicado: (2011)

Ambient Air Pollution and Lipoprotein-Associated Phospholipase A(2) in Survivors of Myocardial Infarction
por: Brüske, Irene, et al.
Publicado: (2011)

Evaluation of lipoprotein-associated Phospholipase A2 in Healthy Chinese Han Adult Serum
por: Feng, Li-Min, et al.
Publicado: (2014)

Correlation between plasma lipoprotein-associated phospholipase A(2) and peripheral arterial disease
por: LI, SHUAI-BING, et al.
Publicado: (2013)

The Role of Lipoprotein-Associated Phospholipase A₂ in a Murine Model of Experimental Autoimmune Uveoretinitis
por: Crawford, G. L., et al.
Publicado: (2015)

Association of lipoprotein‐associated phospholipase A2 mass with asymptomatic cerebral artery stenosis
por: Wang, Youxin, et al.
Publicado: (2018)

The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease
por: Zhang, Hao, et al.
Publicado: (2020)

The role of lipoprotein-associated phospholipase A2 in acute kidney injury of septic mice
por: Liang, Guiwen, et al.
Publicado: (2020)

Lipoprotein-Associated Phospholipase A2 Is a Risk Factor for Patients With Parkinson’s Disease
por: Wu, Zubo, et al.
Publicado: (2021)

Biological Properties and Clinical Significance of Lipoprotein-Associated Phospholipase A(2) in Ischemic Stroke
por: Zhang, Shuang, et al.
Publicado: (2022)

Investigation of the Brain Biodistribution of the Lipoprotein-Associated Phospholipase A(2) (Lp-PLA(2)) Inhibitor [(18)F]GSK2647544 in Healthy Male Subjects
por: Huiban, Mickael, et al.
Publicado: (2016)

Taiwanese Female Vegetarians Have Lower Lipoprotein-Associated Phospholipase A2 Compared with Omnivores
por: Chen, Chih-Wei, et al.
Publicado: (2011)

Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk
por: Colley, Kenneth J., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jjc5tln7u16tlvc2ikjjcqo6uj